Elite Pharmaceuticals schedules Aug 13 release of Q1 FY2027 results, Aug 14 call

ELITE PHARMACEUTICALS INC /NV/

Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
Conference call Friday, August 14, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359 (US), 1-973-528-0008 (intl), conference number 98840.
8-K/A amends prior notice, correcting event dates from November to August 2026.
Stockholder questions accepted via dianne@elitepharma.com; general Qs by Aug 12, financial Qs by Aug 13, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.